메뉴 건너뛰기




Volumn 32, Issue 3, 2010, Pages 404-410

Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital

Author keywords

Antibiotics; Belgium; Clinical pharmacy; Drug administration; Fluoroquinolones; Practice guidelines; Prescribing

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

EID: 77953324068     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-010-9384-y     Document Type: Article
Times cited : (24)

References (22)
  • 1
    • 33646848951 scopus 로고    scopus 로고
    • Antimicrobial Stewardship
    • DOI 10.1016/j.amjmed.2006.04.003, PII S0002934306003482
    • N Fishman 2006 Antimicrobial stewardship Am J Med 119 S53 S61 10.1016/j.amjmed.2006.04.003 16735152 (Pubitemid 43776138)
    • (2006) American Journal of Medicine , vol.119
    • Fishman, N.1
  • 2
    • 0030975692 scopus 로고    scopus 로고
    • Sequential antimicrobial therapy the role of quinolones
    • 10.1093/jac/39.4.441
    • D Nathawani G Tillotson P Davey 1997 Sequential antimicrobial therapy the role of quinolones J Antimicrob Chemother 39 441 446 10.1093/jac/39.4.441
    • (1997) J Antimicrob Chemother , vol.39 , pp. 441-446
    • Nathawani, D.1    Tillotson, G.2    Davey, P.3
  • 4
    • 0032931808 scopus 로고    scopus 로고
    • Early switch from intravenous to oral antibiotics: Guidelines and implementation in a large teaching hospital
    • 10.1093/jac/43.4.601 10350396
    • F Sevinç J Prins R Koopmans P Langendijk P Bossuyt J Dankert P Speelman 1999 Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital J Antimicrob Chemother 43 601 606 10.1093/jac/43.4.601 10350396
    • (1999) J Antimicrob Chemother , vol.43 , pp. 601-606
    • Sevinç, F.1    Prins, J.2    Koopmans, R.3    Langendijk, P.4    Bossuyt, P.5    Dankert, J.6    Speelman, P.7
  • 5
    • 0037111728 scopus 로고    scopus 로고
    • Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from IV to oral
    • 12455304
    • J Kuti T Le C Nightindale D Nicolau R Quintiliani 2002 Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from IV to oral Am J Health Syst Pharm 59 2209 2215 12455304
    • (2002) Am J Health Syst Pharm , vol.59 , pp. 2209-2215
    • Kuti, J.1    Le, T.2    Nightindale, C.3    Nicolau, D.4    Quintiliani, R.5
  • 6
    • 0031015675 scopus 로고    scopus 로고
    • Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones
    • 10.2165/00019053-199711010-00008 1:STN:280:DyaK2s3gvVGksQ%3D%3D 10165528
    • K Jensen J Paladino 1997 Cost-effectiveness of abbreviating the duration of intravenous antibacterial therapy with oral fluoroquinolones Pharmacoeconomics 11 64 74 10.2165/00019053-199711010-00008 1:STN:280: DyaK2s3gvVGksQ%3D%3D 10165528
    • (1997) Pharmacoeconomics , vol.11 , pp. 64-74
    • Jensen, K.1    Paladino, J.2
  • 7
    • 0036179827 scopus 로고    scopus 로고
    • Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia
    • 10.2165/00003495-200262020-00005 1:CAS:528:DC%2BD38XitVWqsbY%3D 11817975
    • F Vogel 2002 Intravenous/oral sequential therapy in patients hospitalised with community-acquired pneumonia Drugs 62 309 317 10.2165/00003495-200262020- 00005 1:CAS:528:DC%2BD38XitVWqsbY%3D 11817975
    • (2002) Drugs , vol.62 , pp. 309-317
    • Vogel, F.1
  • 8
    • 0036000279 scopus 로고    scopus 로고
    • Intravenous to oral conversion of fluoroquinolones: Knowledge versus clinical practice patterns
    • DOI 10.1023/A:1015533503212
    • O Conort S Gabardi M Didier G Hazebroucq A Cariou 2002 Intravenous to oral conversion of fluoroquinolones; knowledge versus clinical practice patterns Pharm World Sci 24 67 70 10.1023/A:1015533503212 12061136 (Pubitemid 34534819)
    • (2002) Pharmacy World and Science , vol.24 , Issue.2 , pp. 67-70
    • Conort, O.1    Fitzpatrick, M.-P.2    Hazebroucq, G.3    Cariou, A.4    Gabardi, S.5
  • 9
    • 0035876195 scopus 로고    scopus 로고
    • Implementing a program for switching from I.V. to oral antimicrobial therapy
    • A Beringer K Nguyen J Razeghi 2001 Implementing a program for switching from I.V. to oral antimicrobial therapy Am J Health Syst Pharm 58 1146 1149
    • (2001) Am J Health Syst Pharm , vol.58 , pp. 1146-1149
    • Beringer, A.1    Nguyen, K.2    Razeghi, J.3
  • 10
    • 0035953115 scopus 로고    scopus 로고
    • Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia
    • 10.1001/archinte.161.6.848 1:STN:280:DC%2BD3M3mtVeluw%3D%3D 11268227
    • J Ramirez J Bordon 2001 Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia Arch Intern Med 161 848 850 10.1001/archinte.161.6.848 1:STN:280:DC%2BD3M3mtVeluw%3D%3D 11268227
    • (2001) Arch Intern Med , vol.161 , pp. 848-850
    • Ramirez, J.1    Bordon, J.2
  • 12
    • 0031871182 scopus 로고    scopus 로고
    • The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards
    • DOI 10.1093/jac/42.1.107
    • R Laing A Mackenzie H Shaw I Gould J Douglas 1998 The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards J Antimicrob Chemother 42 107 111 10.1093/jac/42.1.107 1:CAS:528:DyaK1cXltFOqsr4%3D 9700538 (Pubitemid 28356371)
    • (1998) Journal of Antimicrobial Chemotherapy , vol.42 , Issue.1 , pp. 107-111
    • Laing, R.B.S.1    Mackenzie, A.R.2    Shaw, H.3    Gould, I.M.4    Douglas, J.G.5
  • 13
    • 0030996331 scopus 로고    scopus 로고
    • Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care health facility
    • 1:CAS:528:DyaK2sXjsV2nsLk%3D 9161649
    • M Zamin M Pitre J Conly 1997 Development of an intravenous-to-oral route conversion program for antimicrobial therapy at a Canadian tertiary care health facility Ann Pharmacother 31 564 570 1:CAS:528:DyaK2sXjsV2nsLk%3D 9161649
    • (1997) Ann Pharmacother , vol.31 , pp. 564-570
    • Zamin, M.1    Pitre, M.2    Conly, J.3
  • 14
    • 0038035679 scopus 로고    scopus 로고
    • Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: A pilot study
    • DOI 10.1023/A:1023240829761
    • V Von Gunten V Amos A Sidler J Beney N Troillet J Reymond 2003 Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study Pharm World Sci 25 2 52 55 10.1023/A:1023240829761 (Pubitemid 36547113)
    • (2003) Pharmacy World and Science , vol.25 , Issue.2 , pp. 52-55
    • Von Gunten, V.1    Amos, V.2    Sidler, A.-L.3    Beney, J.4    Troillet, N.5    Reymond, J.-P.6
  • 15
    • 0034035096 scopus 로고    scopus 로고
    • Intravenous to oral (iv:po) anti-infective conversion therapy
    • 1:STN:280:DC%2BD3c3ks1amsw%3D%3D 10783821
    • G Wetzstein 2000 Intravenous to oral (iv:po) anti-infective conversion therapy Cancer Control 7 170 176 1:STN:280:DC%2BD3c3ks1amsw%3D%3D 10783821
    • (2000) Cancer Control , vol.7 , pp. 170-176
    • Wetzstein, G.1
  • 18
    • 0242521391 scopus 로고    scopus 로고
    • Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis
    • 1:CAS:528:DC%2BD3sXovVeku78%3D 14563900
    • F Ansari K Gray D Nathwani G Phillips S Ogston C Ramsay P Davey 2003 Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis JAC 52 842 848 1:CAS:528:DC%2BD3sXovVeku78%3D 14563900
    • (2003) JAC , vol.52 , pp. 842-848
    • Ansari, F.1    Gray, K.2    Nathwani, D.3    Phillips, G.4    Ogston, S.5    Ramsay, C.6    Davey, P.7
  • 19
    • 0037765103 scopus 로고    scopus 로고
    • Interrupted time series analysis in clinical research
    • 10.1345/aph.1A109 12841825
    • L Matowe C Leister C Crivera J Korth-Bradley 2003 Interrupted time series analysis in clinical research Ann Pharmacother 37 1110 1116 10.1345/aph.1A109 12841825
    • (2003) Ann Pharmacother , vol.37 , pp. 1110-1116
    • Matowe, L.1    Leister, C.2    Crivera, C.3    Korth-Bradley, J.4
  • 20
    • 75749089022 scopus 로고    scopus 로고
    • The WHO collaborating centre for drug statistics methodology
    • Oslo, Norway
    • The WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDD's. Oslo, Norway; 2003. http://www.whocc.no/atcddd/. Accessed 3 Apr 2006.
    • (2003) ATC Index with DDD's
  • 22
    • 35748932852 scopus 로고    scopus 로고
    • R Development Core Team Vienna, Austria: R Foundation for Statistical Computing ISBN 3-900051-07-0
    • R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2007. ISBN 3-900051-07-0. http://www.R-project.org. Accessed 2 Jan 2007.
    • (2007) R: A Language and Environment for Statistical Computing


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.